Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics.
about
Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary DiseasesClinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsisPlasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development.Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Neutrophil elastase contributes to acute lung injury induced by bilateral nephrectomy.Essential role for neutrophils in pathogenesis and adaptive immunity in Chlamydia caviae ocular infectionsNeutrophil elastase mediates acute pathogenesis and is a determinant of long-term behavioral recovery after traumatic injury to the immature brainEffect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema StudyCysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function.The use of neutrophil elastase inhibitor in the treatment of acute lung injury after pneumonectomyNeutrophil elastase inhibitors: recent advances in the development of mechanism-based and nonelectrophilic inhibitors.A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium.Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome.Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis.Neutrophil Elastase Inhibitor Following Liver Resection: A Matched Cohort Study.Inhibition of neutrophil elastase contributes to attenuation of lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice.Neutrophil elastase inhibitor prevents ischemic brain damage via reduction of vasogenic edema.The effects of a specific neutrophil elastase inhibitor (ONO-5046) in pulmonary ischemia-reperfusion injury.Complement C5a is a key mediator of meconium-induced neutrophil activation.Septic pulmonary microvascular endothelial cell injury: role of alveolar macrophage NADPH oxidase.Continuous infusion of sivelestat sodium hydrate prevents lipopolysaccharide-induced intestinal paralysis and hypotension in conscious guinea-pigs.Nephrogenic acute respiratory distress syndrome: A narrative review on pathophysiology and treatment.Deficiency in neutrophil elastase does not impair neutrophil recruitment to inflamed sites.A neutrophil elastase inhibitor improves lung function during ex vivo lung perfusion.Feasibility of Computed Tomography in a Multicenter COPD Trial: A Study of the Effect of AZD9668 on Structural Airway Changes.Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases.Treatment of spontaneous esophageal rupture (Boerhaave syndrome) using thoracoscopic surgery and sivelestat sodium hydrate.
P2860
Q28646482-BADD0730-AE99-4E29-9CB3-ACD2C08B8B9CQ33403972-351279F8-B70A-4DC5-8537-FE99F6FDD58BQ33406274-7FDF9276-50E0-4620-96DD-C15942CA7198Q34149948-7A78B6F4-B61E-4B39-A39D-9030D0E56497Q34162310-164E38DD-CF36-481C-A71A-AE9BA720A52BQ34931695-56DE6132-1755-484E-B417-54470E0F5911Q35070570-ACD95FC6-AA4B-4431-9376-3387BEFAE340Q35107091-D2B83616-1BA9-4D9E-9408-21A0EA8FF096Q36822323-6FDF87B7-921E-4885-A648-EDF9F4B8C0A4Q36922246-9A8DE549-AB7B-4AFB-92F1-EFABBE6CF925Q37998133-7AD09761-9052-417C-828D-1AE2ACD08811Q37998175-F364EE8E-CDB6-44B6-A149-1816172FE20BQ38239639-C5EE4F4C-F4E8-4A24-8869-C4D9A2AD6D7FQ38960098-2848C08D-2736-4D0D-9D85-1FE6016B28D9Q40033710-0BEACBE2-1105-4C91-BC23-7011CB9E4767Q40350924-93B48B49-B4F5-476D-A0EB-4FCE8C97A0C6Q43059165-89E3A7AE-74EC-45C6-9178-21433BD65C43Q44449104-00B8C9A2-DCE5-4278-B6B6-74B619B08FBFQ45178548-C491BB2E-D839-4CDF-9056-9025ED68034FQ45266381-413C6166-FDDA-4001-8582-9D94CB60C464Q46697303-FF4E7D97-FA23-4844-A7CC-B032098188DBQ49342932-A68D8EA8-DBC4-43C9-BB39-0E372CB64CD0Q51016463-3BF7052D-6152-499E-9AFA-4A4F58AF3CD9Q51597356-35D3B53E-9160-46B4-9CC7-8491AE88EA1FQ51625172-72C39FC8-1E0F-46B4-91FF-02FF56737B7BQ52728096-3BDFD246-3AFF-44A1-A174-46770E254B63Q55116786-F4C86A68-886E-4965-86E4-CFC204526DC6
P2860
Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@ast
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@en
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@nl
type
label
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@ast
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@en
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@nl
prefLabel
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@ast
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@en
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@nl
P2093
P1476
Neutrophil elastase and acute ...... se inhibitors as therapeutics.
@en
P2093
Bernhardt G Zeiher
John E Repine
Kazuhito Kawabata
Shozo Matsuoka
P304
P356
10.1097/00003246-200205001-00018
P407
P433
P577
2002-05-01T00:00:00Z